Market Introduction
The ATP test is the fast calculation by identification of adenosine triphosphate or ATP of aggressively developing microorganisms. ATP is a molecule in and near living cells that specifically tests the biological production and wellbeing of the organisms. ATP is determined with the natural fire enzyme luciferase by using a luminometer to calculate the light emitted by its reaction.
Market Overview and Dynamics
The Europe Adenosine Triphosphate (ATP) swab test market is expected to reach US$ 113.24 million by 2027 from US$ 62.27 million in 2019. The market is estimated to grow at a CAGR of 7.8% from 2020 to 2027. The growth of the market is attributed to the key driving factors such as rising prevalence of healthcare associated infections (HAI) and increasing emphasis on food safety. However, the limitations of ATP swab tests hinder the market growth.
Key Market Segments
The Europe Adenosine Triphosphate (ATP) Swab Test market, based on type, is segmented into free ATP test and microbial ATP test. In 2019, the microbial ATP test segment held a larger market share, and the market for the same segment is expected to grow at a faster rate during the coming years.
The Europe Adenosine Triphosphate (ATP) Swab Test market, based on the application, is segmented into pharmaceutical & biotechnology company, food & beverage, hospitals & diagnostics laboratories, and academic & research institutions. In 2019, the pharmaceutical & biotechnology company segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest rate during the coming years.
Major Sources and Companies Listed
A Few of the primary and secondary sources associated with this report on the Europe Adenosine Triphosphate (ATP) swab test market are the Cooperative Council of Health Insurance (CCHI), Centers for Disease Control and Prevention (CDC), and World Health organization (WHO).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the Europe Adenosine Triphosphate (ATP) swab test market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe Adenosine Triphosphate (ATP) swab test market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe Adenosine Triphosphate (ATP) swab test market.
EUROPE ADENOSINE TRIPHOSPHATE (ATP) SWAB TEST MARKET SEGMENTATION
By Type
- Free ATP Test
- Microbial ATP Test
By Application
- Pharmaceutical and Biotechnology Company
- Food and Beverage
- Hospitals and Diagnostics Laboratories
- Academic and Research Institutions
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- 3M
- Hygiena, LLC
- Charm Sciences
- Neogen Corporation
- Ecolab
- MERCK KGaA
- Ruhof Healthcare Corporation
- LuminUltra Technologies Ltd.
Europe Adenosine Triphosphate (ATP) Swab Test Market Strategic Insights
Europe Adenosine Triphosphate (ATP) Swab TestMarket Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 62.27 Million |
| Market Size by 2027 | US$ 113.24 Million |
| CAGR (2020 - 2027) | 7.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Adenosine Triphosphate (ATP) Swab Test Market Country and Regional Insights
